Hong-liang Qiu
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Eriodictyol targets the ubiquitination/phosphorylation of apoptosis signal-regulating kinase 1 and alleviates pressure-overload induced myocardial fibrosis in mice.
Journal: British journal of pharmacology
Published: February 17, 2026
Deciphering Uncoupling Proteins in Cellular Homeostasis and Metabolic Health.
Journal: International journal of biological sciences
Published: December 13, 2025
Nuciferine inhibits pressure overload-induced cardiac remodeling by activating the SENP1-ACSL4-ferroptosis axis.
Journal: Journal of advanced research
Published: June 28, 2025
Tectorigenin protects against cardiac fibrosis in diabetic mice heart via activating the adiponectin receptor 1-mediated AMPK pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 26, 2024
Macrod1 suppresses diabetic cardiomyopathy via regulating PARP1-NAD+-SIRT3 pathway.
Journal: Acta pharmacologica Sinica
Published: November 30, 2023
Mangiferin alleviates diabetic pulmonary fibrosis in mice via inhibiting endothelial-mesenchymal transition through AMPK/FoxO3/SIRT3 axis.
Journal: Acta pharmacologica Sinica
Published: July 12, 2023
Identify Tcea3 as a novel anti-cardiomyocyte hypertrophy gene involved in fatty acid oxidation and oxidative stress.
Journal: Frontiers in cardiovascular medicine
Published: January 04, 2023
Screening of Lipid Metabolism-Related Gene Diagnostic Signature for Patients With Dilated Cardiomyopathy.
Journal: Frontiers in cardiovascular medicine
Published: January 12, 2022
Limonin stabilises sirtuin 6 (SIRT6) by activating ubiquitin specific peptidase 10 (USP10) in cardiac hypertrophy.
Journal: British journal of pharmacology
Published: September 06, 2021
Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling Pathway.
Journal: Oxidative medicine and cellular longevity
Published: August 11, 2021
Lupeol protects against cardiac hypertrophy via TLR4-PI3K-Akt-NF-κB pathways.
Journal: Acta pharmacologica Sinica
Published: July 06, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026